Implant for eye pressure in glaucoma or ocular hypertension
Part of Eyes & vision clinical trials.
This trial tests a tiny implant that slowly releases medication inside the eye to lower pressure. It is for people with open-angle glaucoma or high eye pressure who have not had certain eye surgeries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have open-angle glaucoma or high eye pressure in the study eye.
- You have not had any glaucoma surgery in the study eye.
- You have not had argon laser treatment (ALT) in the study eye.
- You have not had a minimally invasive glaucoma surgery (MIGS) in the study eye.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a newer version of a tiny implant placed inside the eye to lower pressure in people with open-angle glaucoma or ocular hypertension. It may offer a treatment option that doesn't require daily eye drops.
This trial tests a new implant that releases medicine for glaucoma while you have cataract surgery. It may help lower eye pressure without using daily drops.
This trial tests if a bimatoprost implant placed during cataract surgery (combined with a special lens) can lower eye pressure better than standard timolol eye drops. It may help people with mild to moderate glaucoma or high eye pressure who are already planning cataract surgery.
This trial tests a sustained-release implant that delivers timolol, a medicine to lower eye pressure, for people with glaucoma or high eye pressure who are also having cataract surgery. The implant is placed during surgery and may provide long-term pressure control without daily eye drops.
This trial tests a tiny implant called Preserflo to treat glaucoma (high eye pressure) that hasn't been controlled with eyedrops. The surgery aims to lower pressure safely while avoiding complications like pressure that drops too low.
This trial compares two types of glaucoma drainage devices (Baerveldt and Paul) in people whose glaucoma is not well controlled with eye drops. It aims to find which device works better at lowering eye pressure and is safer.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.